WTO: Pharma-producing nations remain evasive on TRIPS Agreement review

Author/s
D. Ravi Kanth
TWN

The United States on 26 April appears to have adopted a “diversionary” stance on Colombia’s proposal for a comprehensive review of the implementation of the World Trade Organization’s controversial TRIPS Agreement, saying that it is ready to accommodate the issues as a review of the domestic implementation of the Agreement, which is contrary to the mandate, said people familiar with the development.

At the WTO’s TRIPS Council meeting that concluded on 26 April, the US position seemed like skirting the main issue of a comprehensive review of the implementation of the TRIPS Agreement, which is supported by many developing countries, said people familiar with the discussions.

https://twn.my/title2/intellectual_property/info.service/2024/ip240501.htmhttps://twn.my/title2/intellectual_property/info.service/2024/ip240501.htm

Keywords